Free Newsletter
H1N1 supply oddity continues
Nepal is still waiting for swine flu vaccine. Manufacturers are "unable to produce the required amount of vaccine that they had pledged," says Nirmal Kandel of the World Health Organization. "The delay in production of the vaccine by the manufacturing company has delayed the shipment."
WHO had promised the South Asian country enough Pandemic Influenza A vaccine for about 10 percent of its 31 million citizens by late January, according to a local press report. The first shipments are now expected in March.
Nepal may want to look to Europe and the manufacturers it chose for the swine flu vaccine. France was trying to unload millions of doses last month, as reported. Likewise with Germany and Spain.
- here's the article
Related Articles:
H1N1 oversupply puts earnings at 'modest' risk
Potency drops investigated in H1N1 vaccines
An up and a down for GSK vaccine
Africa rallies against counterfeits
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: